Cargando…

Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia

BACKGROUND: Ceftriaxone (CTX) and penicillin G (PCN G) are considered reasonable treatment options for viridans group streptococci (VGS) bloodstream infections, but comparisons between these agents are limited. We evaluated clinical outcomes among patients treated with these agents for complicated V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wo, Stephanie, Dubrovskaya, Yanina, Siegfried, Justin, Papadopoulos, John, Jen, Shin-Pung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817077/ https://www.ncbi.nlm.nih.gov/pubmed/33511221 http://dx.doi.org/10.1093/ofid/ofaa542

Ejemplares similares

270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

1082. Characterization of Ceftriaxone-Resistant Viridans Streptococci Bacteremia Among Patients at a Comprehensive Cancer Center
por: Marsland, Paula, et al.
Publicado: (2020)

Treatment of Piperacillin-Tazobactam–Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials
por: Cao, John, et al.
Publicado: (2023)

Penicillin-resistant Aerococcus viridans bacteremia associated with granulocytopenia.
por: Uh, Young, et al.
Publicado: (2002)

Insight into the Diversity of Penicillin-Binding Protein 2x Alleles and Mutations in Viridans Streptococci
por: van der Linden, Mark, et al.
Publicado: (2017)

Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci
por: Matsuo, Takahiro, et al.
Publicado: (2021)

1441. Comparison of Cefpodoxime vs. Oral Cefuroxime for Urinary Tract Infections at a Large Academic Medical Center
por: Bao, Hongkai, et al.
Publicado: (2019)

The Role of Corticosteroids in Adult Respiratory Distress Syndrome caused by Viridans Group Streptococci Bacteremia in Neutropenic Patients
por: Yacoub, Abraham T., et al.
Publicado: (2014)

Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia
por: Turner, Nicholas A, et al.
Publicado: (2018)

1819. Characterizing Treatment Duration of Viridans Group Streptococci Bacteremia in Neutropenic Cancer Patients: Is 14 Days Necessary?
por: Vu, Yaling, et al.
Publicado: (2022)

Complicated Isolated Liver Abscess Caused by Viridans Group Streptococci Leading to Right Hepatectomy
por: Ahmed, Muhammad F, et al.
Publicado: (2020)

250. Blood Stream Infections (BSI) in Pediatric Neuroblastoma High Risk: Emphasis on Viridans Group Streptococci (VGS) Bacteremia
por: Alali, Muayad, et al.
Publicado: (2020)

1809. Treatment Outcomes in Piperacillin-tazobactam Non-susceptible (TZP-NS)/Ceftriaxone Susceptible (CRO-S) Infections
por: Dubrovskaya, Yanina, et al.
Publicado: (2022)

Comparative transcriptomic analysis of streptococcus pseudopneumoniae with viridans group streptococci
por: Park, Hee Kuk, et al.
Publicado: (2012)

Microbiology and clinical characteristics of viridans group streptococci in patients with cancer
por: Guerrero-Del-Cueto, Fuensanta, et al.
Publicado: (2018)

1376. Oral Vancomycin as Secondary Prophylaxis Against Clostridioides difficile Infection in Pediatric Patients
por: Bao, Hongkai, et al.
Publicado: (2020)

Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System
por: Greenfield, Adam, et al.
Publicado: (2021)

Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci
por: Chun, Sejong, et al.
Publicado: (2015)

Draft Genome Sequences of Viridans Streptococci Causing Bacterial Endophthalmitis in Humans
por: Marquart, Mary E., et al.
Publicado: (2021)

Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia: A Propensity-Matched, Retrospective Cohort Study
por: Steere, Evan L, et al.
Publicado: (2023)

The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Pliakos, Elina Eleftheria, et al.
Publicado: (2021)

Use of Ceftriaxone and Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Spectrum vs Cost
por: Kalatharan, L, et al.
Publicado: (2023)

Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis
por: Marquart, Mary E., et al.
Publicado: (2018)

Use of 16s rRNA Gene Sequencing for the Identification of Viridans Group Streptococci
por: Menon, Thangam, et al.
Publicado: (2023)

Bacteremia Caused by Group G Streptococci, Taiwan
por: Liao, Chun-Hsing, et al.
Publicado: (2008)

The Sensitivity of Streptococci to Penicillin G After Exposure to the Antibiotic in Vivo
por: Grunberg, E., et al.
Publicado: (1948)

Evaluation of the MicroScan MICroSTREP Plus Antimicrobial Panel for Testing β-Hemolytic Streptococci and Viridans Group Streptococci
por: Kim, Sung Ju, et al.
Publicado: (2011)

222. Oral Step-Down Therapy for Uncomplicated Enterococcus Bacteremia
por: Ni, Jessica, et al.
Publicado: (2023)

Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge
por: Merchan, Cristian, et al.
Publicado: (2016)

Multiple Deep-seated Dentofacial Abscesses Caused by Multidrug-resistant Viridans Group Streptococci
por: Fukushima, Shinnosuke, et al.
Publicado: (2020)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

Highly Variable Streptococcus oralis Strains Are Common among Viridans Streptococci Isolated from Primates
por: Denapaite, Dalia, et al.
Publicado: (2016)

Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020
por: Singh, Nidhi, et al.
Publicado: (2022)

Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis
por: Dhotre, Shree, et al.
Publicado: (2018)

Aerococcus viridans Bacteremia: A Rare Case Report from India
por: Varshini, Krithika, et al.
Publicado: (2022)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

A SEROLOGICAL CLASSIFICATION OF VIRIDANS STREPTOCOCCI WITH SPECIAL REFERENCE TO THOSE ISOLATED FROM SUBACUTE BACTERIAL ENDOCARDITIS
por: Solowey, Mathilde
Publicado: (1942)

185. Trends in Clinical Presentation and Antibiotic Resistance of Viridans Group Streptococci Bloodstream Infections in Immunocompromised Children
por: Quintero, Ana M, et al.
Publicado: (2021)

Amoxicillin and Ceftriaxone as Treatment Alternatives to Penicillin for Maternal Syphilis
por: Katanami, Yuichi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_471k3n0nhal69o8io3ab08qqou